{
    "Trade/Device Name(s)": [
        "ADVIA Centaur HAV IgM Assay",
        "ADVIA Centaur HAV IgM (aHAVM) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K161964",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060770",
        "K081716"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOL"
    ],
    "Summary Letter Date": "July 14, 2016",
    "Summary Letter Received Date": "July 18, 2016",
    "Submission Date": "October 11, 2016",
    "Regulation Number(s)": [
        "21CFR866.3310"
    ],
    "Regulation Name(s)": [
        "Hepatitis A virus (HAV) serological assays"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "IgM response to hepatitis A virus (HAV)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Potassium EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur",
        "ADVIA Centaur XP",
        "ADVIA Centaur XPT",
        "ADVIA Centaur CP"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Methodologies": [
        "IgM capture immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur HAV IgM immunoassay for qualitative detection of IgM to hepatitis A virus in pediatric and adult serum/plasma.",
    "Indications for Use Summary": "In vitro diagnostic immunoassay for qualitative determination of IgM response to hepatitis A virus in pediatric (2\u201321 years) and adult serum/plasma, aiding diagnosis of acute or recent HAV infection using ADVIA Centaur family systems.",
    "fda_folder": "Microbiology"
}